+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Metformin"

Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
From
From
From
From
Diabetes Care Drugs Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Diabetes Care Drugs Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 138 Pages
  • Global
From
From
From
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects. The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more